1. Home
  2. ENTA vs DIN Comparison

ENTA vs DIN Comparison

Compare ENTA & DIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enanta Pharmaceuticals Inc.

ENTA

Enanta Pharmaceuticals Inc.

HOLD

Current Price

$15.22

Market Cap

374.6M

Sector

Health Care

ML Signal

HOLD

Logo Dine Brands Global Inc.

DIN

Dine Brands Global Inc.

HOLD

Current Price

$28.75

Market Cap

360.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENTA
DIN
Founded
1995
1958
Country
United States
United States
Employees
N/A
992
Industry
Biotechnology: Pharmaceutical Preparations
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
374.6M
360.0M
IPO Year
2012
1994

Fundamental Metrics

Financial Performance
Metric
ENTA
DIN
Price
$15.22
$28.75
Analyst Decision
Strong Buy
Hold
Analyst Count
5
7
Target Price
$20.40
$29.00
AVG Volume (30 Days)
123.3K
343.6K
Earning Date
05-11-2026
05-06-2026
Dividend Yield
N/A
2.78%
EPS Growth
29.93
N/A
EPS
N/A
0.57
Revenue
$102,814,000.00
$879,300,000.00
Revenue This Year
$7.76
$3.61
Revenue Next Year
N/A
$0.64
P/E Ratio
N/A
$50.18
Revenue Growth
16.48
8.25
52 Week Low
$5.55
$19.58
52 Week High
$17.15
$39.68

Technical Indicators

Market Signals
Indicator
ENTA
DIN
Relative Strength Index (RSI) 67.77 53.18
Support Level $12.91 $24.09
Resistance Level $15.37 $28.57
Average True Range (ATR) 0.76 1.57
MACD 0.16 0.10
Stochastic Oscillator 81.47 50.97

Price Performance

Historical Comparison
ENTA
DIN

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

About DIN Dine Brands Global Inc.

Dine Brands Global Inc owns and franchises thousands of restaurants under the International House of Pancakes (IHOP), Applebee's Neighborhood Grill + Bar (Applebee's), and the Fuzzy's Taco Shop (Fuzzy's) names. The company conducts its business through three reportable segments: Franchise, Company-owned restaurants, and Rental. The majority of its revenue is generated from the Franchise segment, which consists of IHOP, Applebee's, and Fuzzy's franchise operations and generates revenue mainly from royalties and advertising fees from several IHOP, Applebee's, and Fuzzy's franchised restaurants, in addition to revenues from the sale of proprietary IHOP and Fuzzy's products to its franchisees. Geographically, the majority of the company's revenues is generated from its domestic market.

Share on Social Networks: